ESR1 and breast carcinoma: While the expression level of SERPINA1 was found to be higher in endocrine resistant cells than responsive cells, unexpectedly, the Kaplan Meier survival analysis revealed that high expression of this gene associated with better survival in ER and HER2 positive luminal B subtype of breast cancer.